EP1359930A4 - Novispirines: peptides antimicrobiens - Google Patents

Novispirines: peptides antimicrobiens

Info

Publication number
EP1359930A4
EP1359930A4 EP01946359A EP01946359A EP1359930A4 EP 1359930 A4 EP1359930 A4 EP 1359930A4 EP 01946359 A EP01946359 A EP 01946359A EP 01946359 A EP01946359 A EP 01946359A EP 1359930 A4 EP1359930 A4 EP 1359930A4
Authority
EP
European Patent Office
Prior art keywords
novispirine
antimicrobial peptides
antimicrobial
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01946359A
Other languages
German (de)
English (en)
Other versions
EP1359930A2 (fr
Inventor
Robert I Lehrer
Alan J Waring
Brian F Tack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of Iowa Research Foundation UIRF
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/840,009 external-priority patent/US6492328B2/en
Application filed by University of Iowa Research Foundation UIRF, University of California Berkeley, University of California San Diego UCSD filed Critical University of Iowa Research Foundation UIRF
Publication of EP1359930A2 publication Critical patent/EP1359930A2/fr
Publication of EP1359930A4 publication Critical patent/EP1359930A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
EP01946359A 2000-06-28 2001-06-13 Novispirines: peptides antimicrobiens Withdrawn EP1359930A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60685800A 2000-06-28 2000-06-28
US606858 2000-06-28
US09/840,009 US6492328B2 (en) 2000-06-28 2001-04-19 Novispirins: antimicrobial peptides
US840009 2001-04-19
PCT/US2001/019094 WO2002000839A2 (fr) 2000-06-28 2001-06-13 Novispirines: peptides antimicrobiens

Publications (2)

Publication Number Publication Date
EP1359930A2 EP1359930A2 (fr) 2003-11-12
EP1359930A4 true EP1359930A4 (fr) 2004-07-14

Family

ID=27085347

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01946359A Withdrawn EP1359930A4 (fr) 2000-06-28 2001-06-13 Novispirines: peptides antimicrobiens

Country Status (7)

Country Link
EP (1) EP1359930A4 (fr)
JP (1) JP2004526663A (fr)
AU (1) AU2001268421A1 (fr)
BR (1) BR0112035A (fr)
CA (1) CA2415236A1 (fr)
IL (1) IL153556A0 (fr)
WO (1) WO2002000839A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071293B1 (en) * 1999-08-18 2006-07-04 The University Of Iowa Research Foundation Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt
ATE422894T1 (de) * 2002-03-21 2009-03-15 Cayman Chem Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
WO2005092365A2 (fr) * 2004-03-29 2005-10-06 Novozymes A/S Utilisation pharmaceutique des novispirines
US7148404B2 (en) * 2004-05-04 2006-12-12 Novozymes A/S Antimicrobial polypeptides
JP5384948B2 (ja) * 2007-02-09 2014-01-08 ジェノミディア株式会社 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
GB201115910D0 (en) 2011-09-14 2011-10-26 Univ Manchester Peptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012668A1 (fr) * 1999-08-18 2001-02-22 University Of Iowa Research Foundation Peptides derives de la cathelicidine ayant une activite antimicrobienne a large spectre

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012668A1 (fr) * 1999-08-18 2001-02-22 University Of Iowa Research Foundation Peptides derives de la cathelicidine ayant une activite antimicrobienne a large spectre

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BROGDEN K A ET AL: "The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. UNITED STATES JAN 2001, vol. 45, no. 1, January 2001 (2001-01-01), pages 331 - 334, XP002279449, ISSN: 0066-4804 *
TOSSI A.; TARANTINO C.; ROMEO D.: "DESIGN OF SYNTHETIC ANTIMICROBIAL PEPTIDES BASED ON SEQUENCE ANALOGY AND AMPHIPATHICITY", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 250, no. 2, December 1997 (1997-12-01), BERLIN, DE, pages 549 - 558, XP000978718 *
TRAVIS ET AL: "BACTERICIDAL ACTIVITY OF MAMMALIAN CATHELICIDIN-DERIVED PEPTIDES", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 68, no. 5, May 2000 (2000-05-01), pages 2748 - 2755, XP002157165, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
JP2004526663A (ja) 2004-09-02
WO2002000839A3 (fr) 2003-08-28
BR0112035A (pt) 2006-02-21
CA2415236A1 (fr) 2002-01-03
AU2001268421A1 (en) 2002-01-08
WO2002000839A2 (fr) 2002-01-03
EP1359930A2 (fr) 2003-11-12
IL153556A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
EP1402001A4 (fr) Peptides antimicrobiens et compositions
DE69911579D1 (de) Antimikrobielle peptide
EP1401476A4 (fr) Peptides antagonistes d'igf
EP1359937A4 (fr) Ligands peptidiques modifies
NO982097L (no) Peptider
NO982098D0 (no) Peptider
GB0014870D0 (en) Peptides
NO20025114L (no) Trombopoitein-reseptormodulerende peptid
DE60122873D1 (de) Therapeutische porenbildende peptide
FR2796072B1 (fr) Peptides anti-microbiens de mollusques
FR2813080B1 (fr) Peptides anti-heparine
ATE445634T1 (de) Antimikrobielle peptide
GB0029777D0 (en) Peptides
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
NO20025817D0 (no) Oligopeptider
DE60124915D1 (de) Synthetische peptide gegen neurologische krankheiten
IL159274A0 (en) Antimicrobial peptides
EP1359930A4 (fr) Novispirines: peptides antimicrobiens
NO20032963L (no) Peptidforbindelser
ATE419271T1 (de) Antimikrobielle peptide
EP1359932A4 (fr) Polypeptides tip39
EP1181031A4 (fr) Nouveaux peptides antiangiogeniques
EP1246834A4 (fr) Peptides antimicrobiens epididymaires
EP1159288A4 (fr) Peptides alpha-conotoxine
EP1389126A4 (fr) Retrocyclines : peptides antiviraux et antimicrobiens

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030127

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 38/10 B

Ipc: 7C 07K 14/47 B

Ipc: 7C 07K 7/08 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040528

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1060303

Country of ref document: HK

17Q First examination report despatched

Effective date: 20060919

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061130

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1060303

Country of ref document: HK